IP Library Granted Patent US 12,409,056
Granted Patent B2
US 12,409,056 · App. 18/452,141 · Granted Sep 9, 2025

Methods and devices for deploying and releasing a temporary implant within the body

Inventors: Samuel Moss (Natick, MA); Matthew S. Lake (Natick, MA); Jonathan Wecker (Natick, MA); Shantanu K. Gaur (Natick, MA); Samuel G. Levy (Natick, MA); Bruce A. Horwitz (Natick, MA); Jinyoung Daniel Gwak (Natick, MA)
Assignee: Allurion Technologies, LLC
A61F5/003A61F5/0036A61F5/0046A61F5/0089A61M39/227
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,409,056
App. No.
18/452,141
Granted
Sep 9, 2025
Kind
B2
Abstract

Methods, devices and systems for delivering a device assembly into a gastric or other space within the body, allowing the device to expand to occupy volume within the gastric space and, after an effective period of time, delivering a substance or stimulus to begin breakdown of the expanded device so that it may release from the body.

Claims (30)

1. A medical device for occupying a space within a patient's body, the medical device comprising:

a device body having an interior reservoir;

a fluid filler material configured to expand within the interior reservoir;

a fill valve configured to deliver the fluid filler material into the interior reservoir, wherein expansion of the fluid filler material increases pressure against the fill valve, wherein the fill valve comprises a first layer and a second layer and a flow control material between the first layer and the second layer, wherein the fill valve comprises a first fluid path between the first layer and the second layer, wherein the fluid filler material closes the first fluid path by pressing the first layer and the second layer toward the flow control material such that the first fluid path is closed;

a release channel providing a second fluid path between an exterior of the device body and the interior reservoir;

a restraining element that closes the release channel such that the restraining element temporarily fluidly constrains the release channel closed to prevent fluid transfer between the exterior of the device body and the interior reservoir, wherein the restraining element is monolithic; and

wherein the fluid filler material degrades the restraining element to unseal the release channel.

2. The medical device of claim 1 , wherein the restraining element is physically separated from fluids within the patient's body, wherein the restraining element is within the interior reservoir.

3. The medical device of claim 1 , further comprising an energy storage element coupled to the release channel, wherein the energy storage element is an elastically resilient member, wherein the elastically resilient member is configured to expand the release channel upon degradation of the restraining element.

4. The medical device of claim 1 , wherein the first layer is positioned outside of a surface of the device and comprises a preformed first opening, wherein the second layer is positioned inside of the surface of the device and comprises a preformed second opening, wherein the flow control material is impermeable to fluid, and wherein the fill valve has a first configuration wherein the first fluid path between the first opening and the second opening is configured for access to an interior of the interior reservoir by a catheter, wherein the fill valve has a second configuration wherein the first fluid path is blocked by the flow control material.

5. The medical device of claim 4 , wherein a first region of the flow control material is attached to the first layer, wherein a second region of the flow control material is attached to the second layer.

6. The medical device of claim 5 , wherein in the first configuration the medical device has no internal pressure such that the first layer and the second layer are separated to form part of the first fluid path, wherein in the second configuration the medical device has an internal pressure such that the first layer and the second layer are juxtaposed to block the first fluid path.

7. The medical device of claim 4 , wherein the first layer and the second layer are partially permeable.

8. The medical device of claim 7 , wherein the first layer and the second layer are permeable to fluid material and impermeable to non-fluid material.

9. The medical device of claim 1 , further comprising an exogenous stimuli configured to cause degradation of the restraining element when the exogenous stimuli acts on the restraining element.

10. A medical device for occupying a space within a patient's body, the medical device comprising:

a device body having an interior reservoir;

a fluid filler material configured to expand within the interior reservoir;

a fill valve configured to deliver the fluid filler material into the interior reservoir, wherein expansion of the fluid filler material increases pressure against the fill valve, wherein the fill valve comprises a first layer and a second layer and a flow control material between the first layer and the second layer, wherein the fill valve comprises a first fluid path between the first layer and the second layer, wherein the fluid filler material closes the first fluid path by pressing the first layer and the second layer toward the flow control material such that the first fluid path is closed;

a release channel configured to control flow through a second-first fluid path, where the second fluid path extends between an exterior of the device body and the interior reservoir, the release channel having a sealed configuration preventing flow of the fluid filler material through the second fluid path and an open configuration permitting flow of the fluid filler material through the second fluid path; and

a restraining element that closes the release channel in the sealed configuration such that the restraining element temporarily fluidly constrains the release channel closed to prevent fluid transfer between the exterior of the device body and the interior reservoir, wherein the restraining element is monolithic; and

wherein the fluid filler material degrades the restraining element to unseal the release channel and to assist in opening the release channel.

11. The medical device of claim 10 , wherein the restraining element is physically separated from fluids within the patient's body, wherein the restraining element is within the interior reservoir.

12. The medical device of claim 10 , further comprising an energy storage element coupled to the release channel, wherein the energy storage element is an elastically resilient member, wherein the elastically resilient member is configured to expand the release channel upon breakdown of the restraining element.

13. The medical device of claim 10 , the first layer is positioned outside of a surface of the device and comprises a preformed first opening, wherein the second layer is positioned inside of the surface of the device and comprises a preformed second opening, wherein the flow control material is impermeable to fluid, and wherein the fill valve has a first configuration wherein the first fluid path between the first opening and the second opening is configured for access to an interior of the interior reservoir by a catheter, wherein the fill valve has a second configuration wherein the first fluid path is blocked by the flow control material.

14. The medical device of claim 13 , wherein a first region of the flow control material is attached to the first layer, wherein a second region of the flow control material is attached to the second layer.

15. The medical device of claim 14 , wherein in the first configuration the medical device has no internal pressure such that the first layer and the second layer are separated to form part of the first fluid path, wherein in the second configuration the medical device has an internal pressure such that the first layer and the second layer are juxtaposed to block the first fluid path.

16. The medical device of claim 13 , wherein the first layer and the second layer are partially permeable.

17. The medical device of claim 16 , wherein the first layer and the second layer are permeable to fluid material and impermeable to non-fluid material.

18. The medical device of claim 10 , further comprising an exogenous stimuli configured to cause degradation of the restraining element when the exogenous stimuli acts on the restraining element.

Assignments (12)
CORRECTIVE ASSIGNMENT TO CORRECT PATENT NUMBER 10307269 AND REPLACE IT WITH 10307279 PREVIOUSLY RECORDED ON REEL 67424 FRAME 592. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Feb 11, 2025
From: COMPUTE HEALTH CORP.
To: ALLURION TECHNOLOGIES OPCO, INC.
Reel/Frame 070191/0885 →
CORRECTIVE ASSIGNMENT TO CORRECT THE THE RECORD AND EXPUNGE PATENT NUMBER 10307269 AND REPLACE IT WITH 10307279 PREVIOUSLY RECORDED ON REEL 67428 FRAME 403. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Oct 18, 2024
From: ALLURION TECHNOLOGIES, INC.
To: ALLURION TECHNOLOGIES OPCO, INC.
Reel/Frame 070129/0072 →
CORRECTIVE ASSIGNMENT TO CORRECT THE WRONG PATENT NUMBER 10307269 TO PATENT NUMBER 10307279 PREVIOUSLY RECORDED AT REEL: 67424 FRAME: 403. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Sep 13, 2024
From: COMPUTE HEALTH CORP.
To: ALLURION TECHNOLOGIES OPCO, INC.
Reel/Frame 068935/0273 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECORD AND EXPUNGE PATENT NUMBER 10307269 AND REPLACE IT WITH 10307279 PREVIOUSLY RECORDED ON REEL 67424 FRAME 616. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER AND CHANGE OF NAME. Recorded Sep 13, 2024
From: ALLURION TECHNOLOGIES OPCO, INC.; COMPUTE HEALTH LLC
To: ALLURION TECHNOLOGIES, LLC
Reel/Frame 068997/0947 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER FROM 10307269 TO 10307279 PREVIOUSLY RECORDED ON REEL 67135 FRAME 251. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Jun 25, 2024
From: ALLURION TECHNOLOGIES, LLC
To: RTW INVESTMENTS, LP
Reel/Frame 067838/0268 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER FROM 10307269 TO 10307279 PREVIOUSLY RECORDED ON REEL 67135 FRAME 677. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Jun 25, 2024
From: ALLURION TECHNOLOGIES, LLC
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 067962/0692 →
MERGER AND CHANGE OF NAME Recorded May 15, 2024
From: ALLURION TECHNOLOGIES OPCO, INC.; COMPUTE HEALTH LLC
To: ALLURION TECHNOLOGIES, LLC
Reel/Frame 067424/0616 →
MERGER Recorded May 15, 2024
From: COMPUTE HEALTH CORP.
To: ALLURION TECHNOLOGIES OPCO, INC.
Reel/Frame 067424/0592 →
CHANGE OF NAME Recorded May 15, 2024
From: ALLURION TECHNOLOGIES, INC.
To: ALLURION TECHNOLOGIES OPCO, INC.
Reel/Frame 067428/0403 →
SECURITY INTEREST Recorded Apr 17, 2024
From: ALLURION TECHNOLOGIES, LLC
To: RTW INVESTMENTS, LP
Reel/Frame 067135/0251 →
SECURITY INTEREST Recorded Apr 17, 2024
From: ALLURION TECHNOLOGIES, LLC
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 067135/0677 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2023
From: MOSS, SAMUEL; LAKE, MATTHEW S.; WECKER, JONATHAN; GAUR, SHANTANU K.; LEVY, SAMUEL G.; HORWITZ, BRUCE A.; GWAK, JINYOUNG DANIEL
To: ALLURION TECHNOLOGIES, INC.
Reel/Frame 064636/0221 →
Continuity (15)
Continuation 16909465 · Jun 23, 2020
Continuation 16102483 · Aug 13, 2018
Continuation 14642590 · Mar 9, 2015
Continuation In Part 14069776 · Nov 1, 2013
Continuation In Part 13773516 · Feb 21, 2013
Provisional Application 61762196 · Feb 7, 2013
Provisional Application 61699942 · Sep 12, 2012
Provisional Application 61674126 · Jul 20, 2012
Provisional Application 61663682 · Jun 25, 2012
Provisional Application 61663683 · Jun 25, 2012
Provisional Application 61663433 · Jun 22, 2012
Provisional Application 61647730 · May 16, 2012
Provisional Application 61645601 · May 10, 2012
Provisional Application 61601384 · Feb 21, 2012
Related Publication 20240041628A1 · Feb 8, 2024
References Cited (210)
US 2911988A · Ravn · 1959 [cited by applicant]
US 3586018A · Bogardh et al. · 1971 [cited by applicant]
US 3592207A · Borello · 1971 [cited by applicant]
US 3638733A · De Rouville et al. · 1972 [cited by applicant]
US 3853116A · Bucalo · 1974 [cited by applicant]
US 4133315A · Berman et al. · 1979 [cited by applicant]
US 4141771A · Barker et al. · 1979 [cited by applicant]
US 4253201A · Ross · 1981 [cited by examiner]
US 4370374A · Raabe et al. · 1983 [cited by applicant]
US 4614188A · Bazell et al. · 1986 [cited by applicant]
US 4636213A · Pakiam · 1987 [cited by examiner]
US 4723547A · Kullas et al. · 1988 [cited by applicant]
US 4732188A · Gabrlik et al. · 1988 [cited by applicant]
US 4739758A · Lai et al. · 1988 [cited by applicant]
US 4842007A · Kurtz · 1989 [cited by applicant]
US 4899747A · Garren et al. · 1990 [cited by applicant]
US 4949756A · Melinyshyn et al. · 1990 [cited by applicant]
US 5018665A · Sulmone · 1991 [cited by applicant]
US 5092847A · Pozzo · 1992 [cited by applicant]
US 5181921A · Makita et al. · 1993 [cited by applicant]
US 5222970A · Reeves · 1993 [cited by applicant]
US 5336123A · Laske et al. · 1994 [cited by applicant]
US 5348537A · Wiesner et al. · 1994 [cited by applicant]
US 5496203A · Murray · 1996 [cited by applicant]
US 5507808A · Becker · 1996 [cited by applicant]
US 5595521A · Becker · 1997 [cited by applicant]
US 5632297A · Sciullo et al. · 1997 [cited by applicant]
US 5950624A · Hart · 1999 [cited by applicant]
US 6162251A · Kredovski · 2000 [cited by applicant]
US 6197005B1 · Gerlach et al. · 2001 [cited by applicant]
US 6259953B1 · Lucchesi et al. · 2001 [cited by applicant]
US 6367499B2 · Taku · 2002 [cited by applicant]
US 6375972B1 · Guo et al. · 2002 [cited by applicant]
US 6460541B1 · Shah et al. · 2002 [cited by applicant]
US 6644336B2 · Dolan · 2003 [cited by applicant]
US 6712832B2 · Shah · 2004 [cited by applicant]
US 6814097B2 · Girouard · 2004 [cited by applicant]
US 6939292B2 · Mizuno et al. · 2005 [cited by applicant]
US 7169134B2 · Bills · 2007 [cited by applicant]
US 7172613B2 · Wazne · 2007 [cited by applicant]
US 7485093B2 · Glukhovsky · 2009 [cited by applicant]
US 7854745B2 · Brister et al. · 2010 [cited by applicant]
US 8183227B1 · Perrin et al. · 2012 [cited by applicant]
US 8202291B1 · Brister et al. · 2012 [cited by applicant]
US 8282666B2 · Birk · 2012 [cited by applicant]
US 8287562B2 · Kasic, II · 2012 [cited by applicant]
US 8292911B2 · Brister et al. · 2012 [cited by applicant]
US 8585676B2 · Shah · 2013 [cited by applicant]
US 8628571B1 · Hacohen et al. · 2014 [cited by applicant]
US 8740845B2 · Shah et al. · 2014 [cited by applicant]
US 8784486B2 · Schuessler · 2014 [cited by applicant]
US 8814898B2 · Gaur et al. · 2014 [cited by applicant]
US 8870907B2 · Gaur et al. · 2014 [cited by applicant]
US 8974483B2 · Gaur et al. · 2015 [cited by applicant]
US 9387107B2 · Gaur et al. · 2016 [cited by applicant]
US 9463106B2 · Khieu et al. · 2016 [cited by applicant]
US 9662239B2 · Brister et al. · 2017 [cited by applicant]
US 9827128B2 · Brister et al. · 2017 [cited by applicant]
US 9827129B2 · Gaur et al. · 2017 [cited by applicant]
US 9849018B2 · Wecker et al. · 2017 [cited by applicant]
US 10182932B2 · Moss et al. · 2019 [cited by applicant]
US 10238516B1 · Singh et al. · 2019 [cited by applicant]
US 10307279B2 · Wecker et al. · 2019 [cited by applicant]
US 10470908B2 · Nelson et al. · 2019 [cited by applicant]
US 10583024B2 · Nelson et al. · 2020 [cited by applicant]
US 10588768B2 · Nelson et al. · 2020 [cited by applicant]
US 10729572B2 · Moss et al. · 2020 [cited by applicant]
US 10786379B2 · Gaur et al. · 2020 [cited by applicant]
US 11098813B2 · Nelson · 2021 [cited by applicant]
US 11497900B2 · Chadwick et al. · 2022 [cited by applicant]
US 11559418B2 · Nelson et al. · 2023 [cited by applicant]
US 11766346B2 · Moss et al. · 2023 [cited by applicant]
US 11828377B2 · Nelson · 2023 [cited by applicant]
US 12109138B2 · Nelson et al. · 2024 [cited by applicant]
US 20010018929A1 · Taku · 2001 [cited by applicant]
US 20020183777A1 · Shannon · 2002 [cited by applicant]
US 20020198470A1 · Imran et al. · 2002 [cited by applicant]
US 20030106583A1 · Weng · 2003 [cited by applicant]
US 20030171768A1 · McGhan · 2003 [cited by applicant]
US 20030229263A1 · Connors et al. · 2003 [cited by applicant]
US 20030229384A1 · Mon · 2003 [cited by applicant]
US 20040044353A1 · Gannoe · 2004 [cited by applicant]
US 20040073249A1 · Trotta · 2004 [cited by applicant]
US 20040101540A1 · Cooker · 2004 [cited by applicant]
US 20040146559A1 · Sowden et al. · 2004 [cited by applicant]
US 20040186502A1 · Sampson et al. · 2004 [cited by applicant]
US 20050027261A1 · Weaver et al. · 2005 [cited by applicant]
US 20050033331A1 · Burnett et al. · 2005 [cited by applicant]
US 20050055039A1 · Burnett · 2005 [cited by examiner]
US 20050096750A1 · Kagan et al. · 2005 [cited by applicant]
US 20050150548A1 · Kita et al. · 2005 [cited by applicant]
US 20060004323A1 · Chang et al. · 2006 [cited by applicant]
US 20060058829A1 · Sampson et al. · 2006 [cited by applicant]
US 20060222705A1 · Flanner et al. · 2006 [cited by applicant]
US 20070010791A1 · Drechsler et al. · 2007 [cited by applicant]
US 20070078476A1 · Hull, Sr. et al. · 2007 [cited by applicant]
US 20070207199A1 · Sogin · 2007 [cited by examiner]
US 20070250094A1 · Makower et al. · 2007 [cited by applicant]
US 20080195226A1 · Williams et al. · 2008 [cited by applicant]
US 20080241094A1 · Burnett et al. · 2008 [cited by applicant]
US 20080243071A1 · Quijano et al. · 2008 [cited by applicant]
US 20080249635A1 · Weitzner et al. · 2008 [cited by applicant]
US 20080269555A1 · Paganon et al. · 2008 [cited by applicant]
US 20080276992A1 · Nomichi et al. · 2008 [cited by applicant]
US 20080306441A1 · Brown et al. · 2008 [cited by applicant]
US 20090024227A1 · Lesh · 2009 [cited by applicant]
US 20090048684A1 · Lesh · 2009 [cited by examiner]
US 20090118756A1 · Valencon · 2009 [cited by applicant]
US 20090192535A1 · Kasic · 2009 [cited by applicant]
US 20090259246A1 · Eskaros · 2009 [cited by examiner]
US 20090275919A1 · Todd et al. · 2009 [cited by applicant]
US 20090277515A1 · Pechtold · 2009 [cited by applicant]
US 20090299327A1 · Tilson et al. · 2009 [cited by applicant]
US 20100062057A1 · Berge et al. · 2010 [cited by applicant]
US 20100100116A1 · Brister et al. · 2010 [cited by applicant]
US 20100110311A1 · Sade et al. · 2010 [cited by applicant]
US 20100114311A1 · Becker · 2010 [cited by applicant]
US 20100121224A1 · Toyota et al. · 2010 [cited by applicant]
US 20100137897A1 · Brister · 2010 [cited by examiner]
US 20100168511A1 · Muni et al. · 2010 [cited by applicant]
US 20100174307A1 · Birk · 2010 [cited by applicant]
US 20100193050A1 · Job · 2010 [cited by applicant]
US 20100243065A1 · Zweber · 2010 [cited by applicant]
US 20100246165A1 · Diaz et al. · 2010 [cited by applicant]
US 20100274194A1 · Sobelman et al. · 2010 [cited by applicant]
US 20110004236A1 · Priplata et al. · 2011 [cited by applicant]
US 20110112383A1 · Voss et al. · 2011 [cited by applicant]
US 20110275882A1 · Hutzenlaub et al. · 2011 [cited by applicant]
US 20120141544A1 · Fuisz et al. · 2012 [cited by applicant]
US 20120141545A1 · Fuisz et al. · 2012 [cited by applicant]
US 20120232576A1 · Brister et al. · 2012 [cited by applicant]
US 20120273050A1 · Metzger et al. · 2012 [cited by applicant]
US 20130012980A1 · Brister et al. · 2013 [cited by applicant]
US 20130035711A1 · Schwab et al. · 2013 [cited by applicant]
US 20130165873A1 · Morriss et al. · 2013 [cited by applicant]
US 20130190796A1 · Tilson et al. · 2013 [cited by applicant]
US 20130218190A1 · Gaur et al. · 2013 [cited by applicant]
US 20130267984A1 · Gaur et al. · 2013 [cited by applicant]
US 20130289604A1 · Brister et al. · 2013 [cited by applicant]
US 20130296751A1 · Martin et al. · 2013 [cited by applicant]
US 20140012363A1 · Franano et al. · 2014 [cited by applicant]
US 20140066967A1 · Levy et al. · 2014 [cited by applicant]
US 20140074142A1 · Khieu et al. · 2014 [cited by applicant]
US 20140180252A1 · Gabriel · 2014 [cited by applicant]
US 20140188151A1 · Gaur et al. · 2014 [cited by applicant]
US 20140296903A1 · Gaur et al. · 2014 [cited by applicant]
US 20150196408A1 · Moss et al. · 2015 [cited by applicant]
US 20150305746A1 · Johnson et al. · 2015 [cited by applicant]
US 20160010758A1 · Nomichi et al. · 2016 [cited by applicant]
US 20160045719A1 · Ha et al. · 2016 [cited by applicant]
US 20160109029A1 · Dulin · 2016 [cited by applicant]
US 20160278957A1 · Gaur et al. · 2016 [cited by applicant]
US 20170211715A1 · Balmaceda et al. · 2017 [cited by applicant]
US 20170312111A1 · Sharma et al. · 2017 [cited by applicant]
US 20180042747A1 · Gaur et al. · 2018 [cited by applicant]
US 20180071127A1 · Wecker et al. · 2018 [cited by applicant]
US 20180236203A1 · Franklin et al. · 2018 [cited by applicant]
US 20180311484A1 · Lake et al. · 2018 [cited by applicant]
US 20180344498A1 · Moss et al. · 2018 [cited by applicant]
US 20190076152A1 · Franklin et al. · 2019 [cited by applicant]
US 20190262157A1 · Nelson et al. · 2019 [cited by applicant]
US 20190388258A1 · Nelson et al. · 2019 [cited by applicant]
US 20190388259A1 · Nelson et al. · 2019 [cited by applicant]
US 20200011442A1 · Nelson · 2020 [cited by applicant]
US 20200155335A1 · Nelson et al. · 2020 [cited by applicant]
US 20200188644A1 · Chadwick et al. · 2020 [cited by applicant]
US 20200323672A1 · Moss et al. · 2020 [cited by applicant]
US 20210341069A1 · Nelson · 2021 [cited by applicant]
US 20230120118A1 · Nelson et al. · 2023 [cited by applicant]
US 20240084908A1 · Nelson · 2024 [cited by applicant]
US 20240342366A1 · Nelson et al. · 2024 [cited by applicant]
CA 2925648 · 2007 [cited by applicant]
CA 2865056 · 2013 [cited by applicant]
CN 1387418 · 2002 [cited by applicant]
CN 101384231 · 2009 [cited by applicant]
CN 201977967 · 2011 [cited by applicant]
CN 102883684 · 2013 [cited by applicant]
CN 106029013 · 2016 [cited by applicant]
EP 2139439 · 2010 [cited by applicant]
EP 2817062 · 2014 [cited by applicant]
EP 3117865 · 2017 [cited by applicant]
EP 3720395 · 2020 [cited by applicant]
GB 201514322 · 2015 [cited by applicant]
JP 2008513132 · 2008 [cited by applicant]
JP 2008515464 · 2008 [cited by applicant]
JP 2010523280 · 2010 [cited by applicant]
JP 2011517611 · 2011 [cited by applicant]
JP 2016030000 · 2016 [cited by applicant]
WO WO2000012167 · 2000 [cited by applicant]
WO WO2004075795 · 2004 [cited by applicant]
WO WO2006020929 · 2006 [cited by applicant]
WO WO2009059802 · 2009 [cited by applicant]
WO WO2009059803 · 2009 [cited by applicant]
WO WO2011106157 · 2011 [cited by applicant]
WO WO2013126593 · 2013 [cited by applicant]
WO WO2014074625 · 2014 [cited by applicant]
WO WO2015066545 · 2015 [cited by applicant]
WO WO2016145076 · 2016 [cited by applicant]
WO WO2017136840 · 2017 [cited by applicant]
WO WO2018142761 · 2018 [cited by applicant]
WO WO2019112768 · 2019 [cited by applicant]
WO WO2019165449 · 2019 [cited by applicant]
WO WO2020010359 · 2020 [cited by applicant]
WO WO2020123916 · 2020 [cited by applicant]
U.S. Appl. No. 16/909,465, filed Jun. 23, 2020. [cited by applicant]
U.S. Appl. No. 14/069,776 filed Nov. 1, 2013. [cited by applicant]
U.S. Appl. No. 14/642,590 filed Mar. 9, 2015. [cited by applicant]
U.S. Appl. No. 16/102,483 filed Aug. 13, 2018. [cited by applicant]
U.S. Appl. No. 13/773,516 filed Feb. 21, 2013. [cited by applicant]
Stony Brook Medicine “Obalon Swallowable Balloon Capsules” Feb. 21, 2017, 2 pages. Retrieved from the Internet [Sep. 2, 2020] URL: https://www.youtube.com/watch?v=CEznWcGacLI. [cited by applicant]